Nicoderm nicotine patch data

A report in the Archives of Internal Medicine said that patients can use the Palo Alto company's patch without increasing risk of cardiovascular events.

In the five-week trial in 156 smokers, 36 percent of patients quit who wore the active patch, compared to 22 percent on the placebo (p < 0.05). ...